Nathan Connell: Professional Connections That Stand the Test of Time at ISTH 2026
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared a post on LinkedIn:
“Some people have a way of weaving through your life in the most unexpected ways.
David Brooks and I were part of each other’s Cornell University story as undergraduates before we both found our way into medicine. Years later, it was such a pleasure to reconnect at ISTH 2026 in Paris and see him thriving in his new role as Head of Global Medical Affairs at Incyte.
It’s remarkable how careers evolve. What began as a college friendship has come full circle, giving us the opportunity to spend time together again, this time thinking about how we can advance care and innovation for the inherited bleeding disorders community.
Conferences like the International Society on Thrombosis and Haemostasis (ISTH) annual Congress are about more than the science. They’re also about the people, the relationships that endure over decades, and the unexpected intersections that remind us just how small our world can be.
Great seeing you again, David!
Looking forward to the conversations ahead.”

Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Jul 15, 2026, 05:32Alessandro Ciarcia: Connecting Expertise and Innovation to Transform the Future of TTP Management at ISTH 2026
-
Jul 15, 2026, 05:02Louise St. Germain Bannon: Scientific Collaboration at ISTH 2026
-
Jul 15, 2026, 04:41Heghine Khachatryan: Efgartigimod Shows Promising Results in iTTP
-
Jul 15, 2026, 04:30Sandeep Jagtap: Presenting the Research Behind Pediatric Fondaparinux at ISTH 2026
-
Jul 14, 2026, 19:35Daratumumab in Difficult-to-Treat iTTP: Updated Results from the International DarTTP Study
-
Jul 14, 2026, 17:1610 Posts Not To Miss from ISTH 2026, Part 3
-
Jul 14, 2026, 15:27Dianne E Van Der Wal: Celebrating Scientific Contributions at ISTH 2026
-
Jul 14, 2026, 15:13Alfonso Tafur: RIETE Registry Analysis Supports More Equitable Approaches to VTE Care
-
Jul 14, 2026, 15:03Heghine Khachatryan: Phase III Trial Results Support BAFF-R Inhibition in Corticosteroid-Refractory ITP